A new study has found that reduced glutathione, when combined with entecavir, significantly improves liver function, reduces fibrosis, and enhances HBV-DNA clearance in chronic hepatitis B patients.

A young woman with three kids died within 18 days of being diagnosed with bile duct cancer, which the doctors initially ...

"The FDA is dedicated to supporting new drug development for rare diseases including very rare metabolic diseases like cerebrotendinous xanthomatosis," said Janet Maynard, M.D., M ...

Chenodiol -- a naturally occurring human bile acid also known as chenodeoxycholic acid -- is the first FDA-approved drug indicated for the rare lipid storage disease and autosomal recessive genetic ...

The Armstrongs did honor his wishes. Two years after Robert’s death, the Armstrongs want to use their experience to emphasize ...

Mirum Pharmaceuticals' Ctexli wins FDA approval for CTX, a rare lipid storage disease. The company projects 2025 global sales of $420–$435 million.

However, a newer lupus drug, anifrolumab (brand name Saphnelo), has shown promising results in reducing organ damage, ...

Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.

One place this happens is around the belly button, where tiny veins in the abdominal wall expand and become visible under the ...

While globally linked to obesity and metabolic disorders, Non-Alcoholic Fatty Liver Disease (NAFLD)'s prevalence in India is ...